A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019 Marc EvansFernando Ovalle Commentary Open access 02 January 2019 Pages: 1 - 3
A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes Irene RomeraAna Cebrián-CuencaJesús Reviriego Review Open access 30 November 2018 Pages: 5 - 19
A Review of the Safety and Adverse Event Profile of the Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Juan P. FriasTerry DexAllen Kaplan Review Open access 11 December 2018 Pages: 21 - 33
Pregabalin in the Management of Painful Diabetic Neuropathy: A Narrative Review Shazli AzmiKariem T. ElHaddUazman Alam Review Open access 18 December 2018 Pages: 35 - 56
Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort Luis Alberto VazquezEva Calvo-BonachoAlbert Goday Original Research Open access 14 November 2018 Pages: 57 - 69
Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia Teodora M. Beljić ŽivkovićBoris J. ĐinđićDragan Z. Zdravković Original Research Open access 19 November 2018 Pages: 71 - 80
Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis Hua YangBing TangAnis Ahmed Original Research Open access 19 November 2018 Pages: 81 - 93
Reasonable Glycemic Control Would Help Wound Healing During the Treatment of Diabetic Foot Ulcers Jiali XiangShumin WangZhengyi Tang Original Research Open access 21 November 2018 Pages: 95 - 105
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials Greg FulcherRoopa MehtaStephen C. Bain Original Research Open access 24 November 2018 Pages: 107 - 118
The Effect of Linagliptin versus Metformin Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Tomoya MitaToru HiyoshiHirotaka Watada Original Research Open access 27 November 2018 Pages: 119 - 134
A Single-Blinded Trial Using Resting-State Functional Magnetic Resonance Imaging of Brain Activity in Patients with Type 2 Diabetes and Painful Neuropathy Qing ZhangPeng ZhangJindan Wu Original Research Open access 30 November 2018 Pages: 135 - 147
Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis Jaehyun BaeGyuri KimBong-Soo Cha Original Research Open access 01 December 2018 Pages: 149 - 158
Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia Samuel J. P. MalkinMonika Russel-SzymczykBarnaby Hunt Original Research Open access 07 December 2018 Pages: 159 - 176
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis Keith BoweringHelena W. RodbardChantal Mathieu Original Research Open access 13 December 2018 Pages: 177 - 188
Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5) Robyn K. PollomLiza L. IlagRamón Ortiz Carrasquillo Original Research Open access 02 January 2019 Pages: 189 - 203
Efficacy Comparison of Preprandial and Postprandial Prandilin 25 Administration in Patients with Newly Diagnosed Type 2 Diabetes Using a Continuous Glucose Monitoring System Yong LuoWen-ji NiJian Zhu Original Research Open access 04 January 2019 Pages: 205 - 213
Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study Hiroe NagaikeMakoto OharaTsutomu Hirano Original Research Open access 05 January 2019 Pages: 215 - 228
Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis Sergio ModafferiMarkus RiesVerena Peters Original Research Open access 07 January 2019 Pages: 229 - 243
Association Between Metformin and Sulfonylurea Monotherapies and Cancer Incidence: A Real-World Cohort Study in Shanghai, China Jing-Hong YeMeng-Hua QianLu Ye Original Research Open access 08 January 2019 Pages: 245 - 258
Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes Asma DeebLayla AbdelrahmanKen Strauss Original Research Open access 08 January 2019 Pages: 259 - 267
High Dose Prednisolone Lowers Plasma Glycated Albumin Levels Compared to Actual Glycemic Control: A Retrospective Observational Study Masami MizunoKatsumi IizukaJun Takeda Brief Report Open access 13 December 2018 Pages: 269 - 276
Behavioral Strategies to Lower Postprandial Glucose in Those with Type 2 Diabetes May Also Lower Risk of Coronary Heart Disease Daniel J. CoxKun FangAnn G. Taylor Brief Report Open access 18 December 2018 Pages: 277 - 281
Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series Siwaporn HiranputS. Haris AhmedShazli Azmi Case Series Open access 15 November 2018 Pages: 283 - 289
A Case of Fulminant Type 1 Diabetes with Gastric and Urinary Retention Chuan XingWenqian ZhaoYanjun Wang Case Report Open access 20 November 2018 Pages: 291 - 298
Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial Norbert Joachim TripoltFelix AbererHarald Sourij Study Protocol Open access 11 December 2018 Pages: 299 - 309
Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus Yasuhiro WatanabeNobuichi KuribayashiIchiro Tatsuno Study Protocol Open access 21 December 2018 Pages: 311 - 321
Correction to: Insulin Injection Technique in China Compared with the Rest of the World Zhenqiang SongXiaohui GuoKenneth W. Strauss Correction Open access 19 November 2018 Pages: 323 - 323
Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons Chakrapani BalijepalliRohan ShiraliEric Druyts Correction Open access 05 December 2018 Pages: 325 - 326
Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L Ariel ZismanTerry DexVanita R. Aroda Correction Open access 04 December 2018 Pages: 327 - 327
Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol Christoph SchindlerAndreas L. BirkenfeldStefan R. Bornstein Correction Open access 06 December 2018 Pages: 329 - 331